Furthermore, CTSL released by carcinoma cells has been shown to produce the angiogenesis inhibitor endostatin from collagen XVIII, raising the possibility that CTSL could act as a putative tumor suppressor by inhibiting angiogenesis [50]. This evidence concerns the gene COL18A1 and neoplasm.